Latest news with #ProductionLinkedIncentive
Time of India
2 days ago
- Automotive
- Time of India
Ola Electric FY25 revenue declines 9% to ₹4,645 cr; margins improve as company targets FY26 profitability
Ola Electric reported a 9 per cent decline in revenue for the financial year ended March 31, 2025, with total income falling to ₹4,645 crore from ₹5,126 crore in FY24. The company's net loss increased 22 per cent year-on-year to ₹870 crore, up from approximately ₹713 crore last year. Despite the decline in revenue and rise in losses, Ola Electric posted a 38 per cent year-on-year improvement in gross margins—from 14.8 per cent in FY24 to 20.5 per cent in FY25. Q1 FY26 margins further improved by 10 percentage points over Q4 FY25. The company expects gross margins to rise to around 35 per cent in Q2 FY26, aided by the scale-up of its Gen 3 platform and anticipated Production Linked Incentive (PLI) accruals. Break-even point reduced According to the company's statement, it maintained its leadership in the electric two-wheeler (E2W) segment, delivering 3,59,221 units in FY25 compared to 3,29,549 units in FY24, representing a 30 per cent market share (as per VAHAN data). The company has reduced its Auto segment EBITDA break-even point to under 25,000 units per month through internal cost and network optimisation initiatives—Project Lakshya and Project Vistaar. The Auto segment operating cost was ₹121 crore in April 2025, with a target of ₹110 crore by June 2025. With the ramp-up of Gen 3 scooters, strong uptake of the mass-market S1 X model, and the launch of the Roadster X motorcycle, Ola Electric said it is on track to achieve segment profitability in FY26.>
Time of India
4 days ago
- Business
- Time of India
India's exports set to cross $1 trillion in FY26 on robust global demand, says FIEO
India's total goods and services exports are projected to surge over 21% year-on-year to touch $1 trillion in the fiscal year 2025-26, according to the Federation of Indian Export Organisations ( FIEO ). In 2024-25, the country's exports stood at $824.9 billion. FIEO President S C Ralhan attributed the projected growth to global buyers looking to diversify their sourcing strategies amid ongoing geopolitical and economic uncertainties. 'The free trade agreements, which India is finalising, would also help in pushing the country's outbound shipments,' he noted. For FY26, merchandise exports are expected to rise by 12% to $525-535 billion, up from $437 billion in FY25. Services exports are projected to grow about 20% year-on-year to $465-475 billion, compared to $387 billion last fiscal, PTI reported. Ralhan said that all major sectors are likely to witness robust growth, including electronics, engineering, chemicals, textiles and clothing, pharmaceuticals, and agriculture. Petroleum and gems and jewellery exports are also expected to rebound into positive territory. Export estimates for 2025-26 include $60 billion from electronics and electricals, $40 billion from machinery, $40 billion from chemicals, $30 billion from pharmaceuticals, $70 billion from petroleum products, $23–25 billion from apparel and made-ups, $30–35 billion from gems and jewellery, and $55 billion from agriculture. A key growth driver for the electronics segment will be the Production Linked Incentive (PLI) scheme. Ralhan also pointed to rising trade diversification as a catalyst, especially with U.S. buyers increasingly looking beyond China. As evidence of the shift, Apple supplier Foxconn invested $1.48 billion (around Rs 12,800 crore) in its India unit during May 14–19, according to regulatory filings. 'It is not just Apple—many other companies are also looking at India. Trade diversion from China will bring at least an additional $5 billion worth of opportunity,' said Ajay Sahai, Director General and CEO of FIEO. India's ongoing negotiations for free trade agreements with the UK, the European Free Trade Association (EFTA), and the European Union (EU) are expected to further support export growth. Additionally, an interim trade deal with the U.S., which may exempt India from reciprocal tariffs, could give Indian exporters a competitive edge, Sahai said. In FY25, the gems and jewellery sector saw exports of $29.8 billion, but the sector has experienced a decline over the past two years due to weakening demand and challenges in sourcing natural diamonds. While the outlook remains strong, Sahai cautioned about emerging headwinds, particularly from non-tariff and technical barriers. A major upcoming challenge is the EU's implementation of the Digital Product Passport (DPP) from January 1, 2026. Initially covering electronics, batteries, textiles, and construction materials, the regulation is set for broader rollout by 2030. The DPP will require detailed digital documentation of a product's life cycle—from raw material sourcing to recycling and disposal—which could significantly increase compliance costs, especially for Micro, Small, and Medium Enterprises (MSMEs). 'These are clearly protectionist measures,' Sahai said, warning that failure to comply could lead to shipment rejections or competitiveness loss in the EU market, which is increasingly focused on sustainability. The DPP follows a series of EU regulations including the Carbon Border Adjustment Mechanism, anti-deforestation rules, and the Eco Design Sustainable Product Regulation, all coming into effect from January 1, 2026. On a positive note, Sahai mentioned that geopolitical disruptions in key trade routes like the Red Sea have subsided, with shipping operations gradually resuming despite recent conflicts in the Russia-Ukraine and Israel-Hamas regions.
Business Upturn
4 days ago
- Business
- Business Upturn
Nuvama cuts Aurobindo Pharma target to Rs 1,485 but retains ‘Buy' on healthy EBITDA margin
By News Desk Published on May 28, 2025, 08:26 IST Nuvama Institutional Equities has retained its Buy rating on Aurobindo Pharma (ARBP) but revised its target price down to ₹1,485 from ₹1,677, citing a mixed Q4 performance and a cautious FY26 outlook. The brokerage said revenue and adjusted EBITDA beat expectations, but PAT (profit after tax) missed estimates. Nuvama noted that the adjusted EBITDA margin of 22.6% was better than anticipated, reflecting effective cost control and operational efficiency. The management has guided for single-digit growth and flat margins in FY26, while FY27 is expected to benefit from new product launches and biosimilar contributions in Europe. This could support stronger performance in the medium term. Despite the margin outperformance, Nuvama has reduced its PAT estimates for FY26E and FY27E by 5% and 4% respectively, factoring in lower earnings visibility and conservative growth assumptions. The report also flagged a potential future trigger in the form of a government announcement on minimum input price for PLI (Production Linked Incentive) scheme products, which could support sector margins. Disclaimer: The views and recommendations expressed above are those of the brokerage firm. Business Upturn does not endorse or offer any investment advice. News desk at
Time of India
4 days ago
- Business
- Time of India
India's exports set to cross $1 trillion in FY26 on robust global demand, says FIEO
India's total goods and services exports are projected to surge over 21% year-on-year to touch $1 trillion in the fiscal year 2025-26, according to the Federation of Indian Export Organisations (FIEO). In 2024-25, the country's exports stood at $824.9 billion. FIEO President S C Ralhan attributed the projected growth to global buyers looking to diversify their sourcing strategies amid ongoing geopolitical and economic uncertainties. 'The free trade agreements, which India is finalising, would also help in pushing the country's outbound shipments,' he noted. For FY26, merchandise exports are expected to rise by 12% to $525-535 billion, up from $437 billion in FY25. Services exports are projected to grow about 20% year-on-year to $465-475 billion, compared to $387 billion last fiscal, PTI reported. R by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Добро пожаловать в Аравию SAUDI Забронировать Undo alhan said that all major sectors are likely to witness robust growth, including electronics, engineering, chemicals, textiles and clothing, pharmaceuticals, and agriculture. Petroleum and gems and jewellery exports are also expected to rebound into positive territory. Export estimates for 2025-26 include $60 billion from electronics and electricals, $40 billion from machinery, $40 billion from chemicals, $30 billion from pharmaceuticals, $70 billion from petroleum products, $23–25 billion from apparel and made-ups, $30–35 billion from gems and jewellery, and $55 billion from agriculture. A key growth driver for the electronics segment will be the Production Linked Incentive (PLI) scheme. Ralhan also pointed to rising trade diversification as a catalyst, especially with U.S. buyers increasingly looking beyond China. As evidence of the shift, Apple supplier Foxconn invested $1.48 billion (around Rs 12,800 crore) in its India unit during May 14–19, according to regulatory filings. 'It is not just Apple—many other companies are also looking at India. Trade diversion from China will bring at least an additional $5 billion worth of opportunity,' said Ajay Sahai, Director General and CEO of FIEO. India's ongoing negotiations for free trade agreements with the UK, the European Free Trade Association (EFTA), and the European Union (EU) are expected to further support export growth. Additionally, an interim trade deal with the U.S., which may exempt India from reciprocal tariffs, could give Indian exporters a competitive edge, Sahai said. In FY25, the gems and jewellery sector saw exports of $29.8 billion, but the sector has experienced a decline over the past two years due to weakening demand and challenges in sourcing natural diamonds. While the outlook remains strong, Sahai cautioned about emerging headwinds, particularly from non-tariff and technical barriers. A major upcoming challenge is the EU's implementation of the Digital Product Passport (DPP) from January 1, 2026. Initially covering electronics, batteries, textiles, and construction materials, the regulation is set for broader rollout by 2030. The DPP will require detailed digital documentation of a product's life cycle—from raw material sourcing to recycling and disposal—which could significantly increase compliance costs, especially for Micro, Small, and Medium Enterprises (MSMEs). 'These are clearly protectionist measures,' Sahai said, warning that failure to comply could lead to shipment rejections or competitiveness loss in the EU market, which is increasingly focused on sustainability. The DPP follows a series of EU regulations including the Carbon Border Adjustment Mechanism, anti-deforestation rules, and the Eco Design Sustainable Product Regulation, all coming into effect from January 1, 2026. On a positive note, Sahai mentioned that geopolitical disruptions in key trade routes like the Red Sea have subsided, with shipping operations gradually resuming despite recent conflicts in the Russia-Ukraine and Israel-Hamas regions. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Associated Press
4 days ago
- Business
- Associated Press
India Diagnostic Laboratories Market Report 2025: Market Set to Double by 2030, Driven by Healthcare Awareness & Tech Advancements
DUBLIN--(BUSINESS WIRE)--May 27, 2025-- The 'Diagnostic Laboratories Market in India (2025 - 2030)' report has been added to offering. The diagnostic laboratories market in India was valued at INR 1.54 Trn in FY 2024. It is expected to reach INR 2.98 Trn by FY 2030, expanding at a compound annual growth rate (CAGR) of ~11.70% during the FY 2025 - FY 2030 period. India's diagnostic laboratory market is poised for substantial growth, driven by rising healthcare awareness, technological advancements, and a growing burden of chronic diseases. The sector is a key component of the healthcare system, facilitating early disease detection and treatment planning. Government initiatives such as the Production Linked Incentive (PLI) scheme and increased foreign investments are expected to further boost this market. The industry is seeing rapid digitization, enhancing accessibility to quality diagnostic services across both urban and rural areas. Factors such as an aging population, increased disposable income, and the shift towards preventive healthcare are fueling growth. The sector comprises both standalone laboratories and hospital-based diagnostic centers, with In Vitro Diagnostics (IVD) playing a crucial role in market expansion. The government's push for local manufacturing, coupled with the PLI 2.0 scheme, aims to enhance domestic production capabilities. India is also a leading hub for medical tourism, contributing to the rising demand for high-quality diagnostics. Market segmentation: India's diagnostic laboratories market comprises two segments: pathology and radiology. Pathology services, including biochemistry, hematology, and microbiology, dominate the market. The IVD sector, covering RT-PCR, ELISA, and molecular diagnostics, is projected to grow significantly due to increasing demand for early disease detection. The radiology segment, covering X-rays, MRI, CT scans, and ultrasound, is witnessing technological advancements. Digital imaging and AI-powered diagnostics are streamlining operations. The Make in India initiative has encouraged domestic manufacturing of high-end imaging equipment, reducing dependency on imports. Tele-radiology services are gaining traction, allowing specialists to analyze scans remotely, particularly in rural areas. Market trends: The Indian diagnostic laboratories market is undergoing significant transformation, driven by the adoption of digital technologies and a shift towards personalized healthcare. The rise of AI-powered diagnostics, cloud-based platforms, and wearable technology is enhancing test accuracy, speed, and accessibility. Preventive healthcare is gaining traction, with increasing demand for genetic testing, early cancer screening, and wellness packages. Government and private investments, including the PLI scheme and FDI policies, are fostering local manufacturing of diagnostic equipment, reducing reliance on imports and lowering costs. Point-of-care (POC) testing is expanding, providing quick, cost-effective diagnostics in remote areas, while home-based testing is becoming mainstream, supported by mobile sample collection and AI-driven analysis. These trends are collectively shaping a more efficient and patient-centric diagnostic ecosystem in India. Key Topics Covered: Chapter 1: Executive Summary Chapter 2: Socio-economic Indicators Chapter 3: Introduction 3.1. Market Definition and Structure Chapter 4: Market Overview 4.1. India Diagnostic Laboratories Market Overview 4.1.1. Market Size and Growth Forecast Based on Value (FY 2022 - FY 2030e) 4.2. India Diagnostic Laboratories Market Segmentation -Based on Diagnostic Test Type 4.3. Region-wise Labs Accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL) 4.4. Regulatory Bodies of Diagnostics Labs Market in India 4.5. Distribution of Diagnostics Labs in India (FY 2023) Chapter 5: Market Segmentation 5.1. India Diagnostic Laboratories Market Segmentation - Based on Diagnostic Test Type 5.2. Pathology Market Size and Growth Forecast (FY2022 - FY2030e) 5.3. Radiology Market Size and Growth Forecast (FY 2022 - FY 2030e) Chapter 6: Market Influencers 6.1. Market Drivers 6.2. Market Challenges Chapter 7: Market Trends 7.1. Key Market Trends Chapter 8: Government Initiatives 8.1. Favorable Government Initiatives Chapter 9: Competitive landscape 9.1. Dr. Lal Pathlabs Limited Note: Financial information has been covered only for public companies. 9.2. Metropolis Healthcare Limited 9.3. Suraksha Diagnostic Limited 9.4. Thyrocare Technologies Limited 9.5. Vijaya Diagnostic Centre Limited 9.6. Agilus Diagnostics Limited 9.7. Apollo Diagnostics 9.8. MEDall Healthcare Private Limited 9.9. RedCliffe Labs Chapter 10: Recent developments For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDIA ASIA PACIFIC INDUSTRY KEYWORD: SCIENCE HEALTH OTHER SCIENCE OTHER HEALTH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 05/27/2025 10:15 AM/DISC: 05/27/2025 10:14 AM
